ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
NEW YORK, Sept. 29, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the “Class Period”), of the important October 6, 2025 lead plaintiff deadline. So What: If you purchased Altimmune securities you may be entitled to compensation without payment of any out





















